郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy.

期刊：Atherosclerosis发表年份：2012作者：Natacha Bellanger; Zélie Julia; Elise F Villard; Petra El Khoury; Emilie Duchene; M John Chapman; Natalie Fournier; Wilfried Le Goff; Maryse Guerin
阅读更多 →

药效评价Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation.

期刊：British journal of pharmacology发表年份：2012作者：A Lehmann; M Antonsson; A Aurell-Holmberg; L A Blackshaw; L Brändén; T Elebring; J Jensen; L Kärrberg; J P Mattsson; K Nilsson; S S Oja; P Saransaari; S von Unge
阅读更多 →

药效评价The LRRC26 protein selectively alters the efficacy of BK channel activators.

期刊：Molecular pharmacology发表年份：2012作者：Janos Almassy; Ted Begenisich
阅读更多 →

药效评价M channel enhancers and physiological M channel block.

期刊：The Journal of physiology发表年份：2012作者：John E Linley; Louisa Pettinger; Dongyang Huang; Nikita Gamper
阅读更多 →